AUDIKA

Córdoba 14001

0 studies enrolling now · 2 studies all time

What they study most

Active Nonsegmental Vitiligo, Stable Nonsegmental Vitiligo, Vitiligo

Studies at this site

• A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo — Running, not enrolling
• A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo — Completed